Your browser doesn't support javascript.
loading
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
Hurtado, Ana M; Luengo-Gil, Gines; Chen-Liang, Tzu H; Amaral, Fabio; Batta, Kiran; Palomo, Laura; Lumbreras, Eva; Przychodzen, Bartlomiej; Caparros, Eva; Amigo, Maria L; Diez-Campelo, Maria; Zamora, Lurdes; Salido Fierrez, Eduardo J; Maciejewski, Jaroslaw P; Ortuño, Francisco J; Vicente, Vicente; Del Canizo, Maria; Sole, Francesc; Ferrer-Marin, Francisca; Wiseman, Daniel H; Jerez, Andres.
Afiliação
  • Hurtado AM; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Luengo-Gil G; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Chen-Liang TH; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Amaral F; Leukaemia Biology Laboratory, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, UK.
  • Batta K; Division of Cancer Sciences, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, UK.
  • Palomo L; Josep Carreras Leukaemia- Research Institute, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Lumbreras E; Department of Haematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Przychodzen B; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, USA.
  • Caparros E; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Amigo ML; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Diez-Campelo M; Department of Haematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Zamora L; Josep Carreras Leukaemia- Research Institute, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Salido Fierrez EJ; Department of Haematology, Virgen de la Arrixaca University Hospital, IMIB, Murcia, Spain.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, USA.
  • Ortuño FJ; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Vicente V; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
  • Del Canizo M; Department of Haematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Sole F; Josep Carreras Leukaemia- Research Institute, ICO-Hospital Germans Trias i Pujol, Badalona, Spain.
  • Ferrer-Marin F; Haematology Department, Hospital Morales Meseguer, IMIB-CIBERERUCAM, Murcia, Spain.
  • Wiseman DH; Leukaemia Biology Laboratory, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, UK.
  • Jerez A; Haematology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain.
Br J Haematol ; 182(3): 373-383, 2018 08.
Article em En | MEDLINE | ID: mdl-29797327

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Proteínas de Ligação a DNA / Reparo do DNA / Endonucleases / Inibidor de Quinase Dependente de Ciclina p21 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielomonocítica Crônica / Proteínas de Ligação a DNA / Reparo do DNA / Endonucleases / Inibidor de Quinase Dependente de Ciclina p21 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article